The portfolio maintains a cost advantage over competitors, priced within the lowest fee quintile among peers.
SPDR® S&P Biotech ETF XBI
Morningstar’s Analysis XBI
Will XBI outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 12.7
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Alpine Immune Sciences Inc | 1.89 | 124.0 Mil | Healthcare |
Revolution Medicines Inc Ordinary Shares | 1.26 | 82.8 Mil | Healthcare |
Exelixis Inc | 1.22 | 80.1 Mil | Healthcare |
Biomarin Pharmaceutical Inc | 1.22 | 79.6 Mil | Healthcare |
Moderna Inc | 1.21 | 79.3 Mil | Healthcare |
Exact Sciences Corp | 1.21 | 79.0 Mil | Healthcare |
Natera Inc | 1.18 | 77.1 Mil | Healthcare |
Crinetics Pharmaceuticals Inc | 1.17 | 76.9 Mil | Healthcare |
Roivant Sciences Ltd Ordinary Shares | 1.17 | 76.6 Mil | Healthcare |
Cytokinetics Inc | 1.16 | 76.3 Mil | Healthcare |